The Digital Medicine Society (DiMe) announced today a new collaboration with Acclinate, Amgen, GSK, Lightship, Medable, Rubix LS, Sage Bionetworks, Savvy Cooperative, and THREAD Research to drive inclusion in digital clinical trials. The initiative aims to provide the tools and framework necessary to successfully integrate diverse perspectives during the planning process for trials that include a technology device for participation.
At Acclinate, our mission is to empower Black and Brown individuals to take actions for better health through our community platform, NOWINCLUDED. As ...
When news broke that R&B legend D’Angelo had passed from pancreatic cancer, it was both a moment of heartbreak and reflection. Not only did we los...
Community wellbeing doesn’t start with pamphlets, events, or dashboards. It starts with agency—with people believing they can take action for their ow...
When people hear the phrase “growth mindset,” they often picture expansion—adding more, moving faster, reaching farther. But for me, growth is about f...
I magine a woman named Mariah. She's 58, managing type 2 diabetes, and juggling caregiving duties. She leaves a doctor's appointment with a pamphlet s...
It's time to admit it. The traditional playbook for diversity in clinical trials is broken. Why? It was built on a flawed premise: that a list of name...
The best projects I’ve been part of have one thing in common: people who stay accountable to the mission, not just the milestones. Planning matters, b...
.jpg?width=300&name=64ee7ebf711c42cfdd7beae3_hush-naidoo-jade-photography-pA0uoltkwao-unsplash%20(3).jpg)
